NatImmune Overview

  • Founded
  • 2000
  • Status
  • Acquired/​Merged
  • Employees
  • 29
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $9.4M
Latest Deal Amount

NatImmune General Information


Developer of protein-based therapeutic treatments. The company engages in the treatment of cancer and infectious diseases through their targeted therapeutic treatment.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • Symbion Science Park
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NatImmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 26-Jun-2009 $9.4M 000.00 00.00 Completed Generating Revenue
3. Early Stage VC 03-Dec-2003 00.000 000.00 Completed Startup
2. Early Stage VC 15-Mar-2000 $7.5M $9.5M Completed Startup
1. Seed Round 01-Jan-2000 $2M $2M Completed Startup
To view NatImmune’s complete valuation and funding history, request access »

NatImmune Executive Team (5)

Name Title Board Seat Contact Info
Jens Jensenius Co-Founder
Steffen Thiel Ph.D Co-Founder
Martin Bonde Ph.D Chief Executive Officer
Alan Ezekowitz MD Co-Founder & Board Member
Per Fischer Ph.D Co-Founder
To view NatImmune’s complete executive team members history, request access »

NatImmune Board Members (1)

Name Representing Role Since
Alan Ezekowitz MD Self Co-Founder & Board Member 000 0000
To view NatImmune’s complete board members history, request access »

NatImmune Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NatImmune Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dansk Erhvervsinvestering Venture Capital Minority 000 0000 000000 0
Kommunernes Pensionsforsikring Corporation Minority 000 0000 000000 0
Novo Holdings Venture Capital Minority 000 0000 000000 0
Vækstfonden Venture Capital Minority 000 0000 000000 0
To view NatImmune’s complete investors history, request access »